scholarly journals COVID-19: A positive prospect of pandemic situation

2021 ◽  
Vol 58 (1) ◽  
pp. 2912-2914
Author(s):  
Vinod Kumar Et al.
Keyword(s):  
Air Pollution ◽  
Mortality Rate ◽  
Severe Acute Respiratory Syndrome ◽  
East Asian ◽  
Preventive Measure ◽  
Human Race ◽  
Wuhan City ◽  
Significant Drop ◽  
The World ◽  
Short Span

In 2019, human race again came across a highly transmittable and pathogenic viral infection viz. COVID-19 and along with its pandemic nature, caused severe acute respiratory syndrome (SARS), and owes its emergence from the local seafood market of Wuhan city, China. Corona virus is currently prevalent all over the world wherein it caused infection in more than 1,30,000 individuals worldwide with mortality rate nearby 3% in approximately 120 countries within a short span of time and the infection due to this virus is still on a higher verge. Apart from this as per WHO report on air pollution revealed around 2.4 and 2.2 million deaths in South East Asian and Western Pacific regions respectively. Both conditions are deadly in their respective prospects, although lockdown, preventive measure which avoid spreading of COVID-19 infection, indirectly lead to significant drop down in air pollution globally. However, this effect is not permanent and it is for being a time but it develops a hope that together we can fight against both.

Plasma therapy a possible hope to fight against COVID-19

2020 ◽  
Author(s):  
Ravikant Piyush ◽  
Aroni Chatterjee ◽  
Shashikant Ray
Keyword(s):  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
Viral Disease ◽  
Plasma Therapy ◽  
Therapeutic Drugs ◽  
Wild Fire ◽  
The World ◽  
Short Span ◽  
Game Changer

The world is currently going through a disastrous event and a catastrophic upheaval caused by the coronavirus disease 2019 (COVID-19). The pandemic has resulted in loss of more than 150000 deaths across the globe. Originating from China and spreading across all continents within a short span of time, it has become a matter of international emergency. Different agencies are adopting diverse approaches to stop and spread of this viral disease but still now nothing confirmatory has come up. Due to lack of vaccines and proper therapeutic drugs, the disease is still spreading like wild fire without control. An Old but very promising method- the convalescent plasma therapy could be the key therapy to stop this pandemic. This method has already proven its mettle on several occasions previously and has been found to be effective in curing the pandemics induced by Ebola, severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) belongs to the same group of β-Coronavirus that has resulted in the above diseases. Therefore, the role of plasma therapy is being explored for treatment of this disease. In this review, we have mainly focused on the role of convalescent plasma therapy and why its use should be promoted in fight against COVID-19, as it could turn out to be a game changer.

Impact OF Covid-19 on Several Industries in Context with the Dialysis Industry

2021 ◽  
Vol 8 (2) ◽  
pp. 01-03
Author(s):  
Ashish Gujrathi
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
World Health Organization ◽  
World Health ◽  
Healthcare Sector ◽  
Growth Opportunities ◽  
Wuhan City ◽  
First Case ◽  
The World ◽  
New Challenges ◽  
Health Organization

Coronavirus (COVID-19) was recognized in late December in Hubei province of Wuhan city in China. This highly contagious disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from humans to humans. After the first case in Wuhan, the disease rapidly spread to other parts of the globe. On March 11, 2020, the World Health Organization (WHO) made an assessment that COVID-19 can be characterized as a pandemic. Thus, social-distancing became an important measure to stop the spread of this disease. Various countries across the world adopted nationwide lockdowns. This led to a completely new scenario for the world, where every business in each industry faced new challenges and witnessed new opportunities. Similarly, the medical personal protective industry, a vital part of the healthcare sector, also witnessed new growth opportunities.

scholarly journals Molecular Docking Study of the Potential Relevance of the Natural Compounds Isoflavone and Myricetin to COVID-19

2021 ◽  
Vol 25 (3) ◽  
pp. 271-282
Author(s):  
Didik Priyandoko ◽  
◽  
Wahyu Widowati ◽  
Mawar Subangkit ◽  
Diana Jasaputra ◽  
...  
Keyword(s):  
Molecular Docking ◽  
Severe Acute Respiratory Syndrome ◽  
Active Sites ◽  
Docking Study ◽  
Binding Mode ◽  
Molecular Docking Study ◽  
Wuhan City ◽  
The World ◽  
Novel Coronavirus ◽  
Proteins Interactions

The 2019 novel coronavirus (2019-nCoV) or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly from its origin in Wuhan City, Hubei Province, China, to the rest of the world. The efficacy of herbal treatment in the control of contagious disease was demonstrated during the 2003 outbreak of severe acute respiratory syndrome (SARS). Natural compound used for this study were isoflavone and myricetin. Molecular docking was performed to analyze binding mode of the compounds towards 12 proteins related to COVID-19. The prediction shows that isoflavone and myricetin have moderate probability of antiviral activity. All of the docked compounds occupied the active sites of the proteins related to COVID-19. Based on QSAR and molecular docking, interactions were predicted with 10 out of 12 potential COVID-19 proteins for myricetin and with 9 out of 12 proteins interactions for isoflavone. A potential disease alleviating action is suggested for isoflavone and myricetin in the context of COVID-19 infection.

scholarly journals Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): Epidemiology and Vaccinology in Nigeria

2021 ◽  
Vol 9 (2) ◽  
pp. 60-69
Author(s):  
Ridwan Olamilekan Adesola ◽  
Oluwatobi Emmanuel Oladele ◽  
Ahmed Oluwasegun Tajudeen ◽  
Ogundepo Oluwatobi Moses ◽  
Murali Dinesh
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
Viral Infections ◽  
World Health ◽  
Great Level ◽  
Global Public Health ◽  
Wuhan City ◽  
Health Authorities ◽  
Global Pandemic ◽  
The World ◽  
Health Organization

Coronavirus disease 2019 (COVID-19), confirmed as the global pandemic on March 11, 2020, by the World Health Organization (WHO), was caused by the outbreak of an emergent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was first reported in Wuhan city, China, in December 2019. Based on the previous pandemic, such as severe acute respiratory syndrome (SARS) from 2002 to 2003, Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012. The scientific developments have fast-tracked our insights SARS-CoV-2 epidemiology, likewise vaccinology relevant for developing drugs for viral infections treatment. As there are not many detailed interventions and vaccines available for disease control, the pandemic COVID-19 poses countless threats to global public health, causing a great level of insecurity and unrest worldwide. To provide an inclusive overview to global health authorities and prospective readers worldwide, we detailed in this review the epidemiology and vaccinology of SARS-CoV-2 in Nigeria.

scholarly journals The Covid-19 Between State of Emergency and Exception in Italy and Its Consequences on Human Rights

2020 ◽  
Vol 3 (2) ◽  
pp. 139
Author(s):  
Pina Sodano Omizzolo
Keyword(s):  
Human Rights ◽  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
World Health Organization ◽  
Social Consequences ◽  
World Health ◽  
Wuhan City ◽  
State Of Emergency ◽  
The World ◽  
Health Organization

In mid-December 2019, several atypical cases of pneumonia were detected in hospitals in Wuhan City – Hubei Province – in Inner China. It turns out that the first patients had already fallen ill in early December or even mid-November. However, only on the last day of the year 2019, Chinese doctors were able to officially identify a new virus in a 41-year-old patient admitted 5 days earlier. The virus belongs to the class of “coronavirus”, the same to which the SARS (Severe Acute Respiratory Syndrome) and MERS (Middle East Respiratory Syndrome) viruses belong. It is initially baptized 2019-nCov, or “new 2019 coronavirus”. In February, the official name assigned to the virus is Sars-COV-2 and the associated disease is named COVID-19. The outbreak took on considerable proportions in China and then spread to the rest of the world, leading the World Health Organization to declare the infection a “pandemic” on 11 March 2020. The containment strategies applied in the most affected countries have proved to be very different in effectiveness, to the point that the lethality of the virus appears very different from country to country. This difference in impact has led to different legal, economic and social consequences.

Revisiting the antiviral efficacy of terpenoids: Plausible adjunct therapeutics for novel SARS-CoV-2?

2021 ◽  
Vol 21 ◽  
Author(s):  
Afza Ahmad ◽  
Rohit Kumar Tiwari ◽  
Irfan Ahmad Ansari
Keyword(s):  
Mortality Rate ◽  
Severe Acute Respiratory Syndrome ◽  
Scientific Literature ◽  
Bioactive Constituents ◽  
Plant Metabolites ◽  
Secondary Plant Metabolites ◽  
Chemical Structures ◽  
Antiviral Efficacy ◽  
The World ◽  
History Of

: Presently the world is witnessing most devastating pandemic in the history of mankind caused due to Severe Acute Respiratory Syndrome or SARS-CoV-2. This dreaded pandemic is responsible for escalated mortality rate across the globe and thus is the worst catastrophes in the history of mankind. Since its outbreak, substantial scientific explorations focusing on formulation of novel therapeutical and/or adjunct intervention against the disease are continuously in pipeline. However, till date no effective therapy has been approved and hence the present alarming situation urges the necessity of exploring novel, safe and efficient interventional strategies. Functionally, terpenoids are a class of secondary plant metabolites having multi facet chemical structures and are categorically documented to be the largest reservoir of bioactive constituents, predominant in nature. Intriguingly, very little is scientifically explored or reviewed in regards with the anti-CoV-2 attributes of terpenoids. The present article thus aims to revisit the antiviral efficacy of terpenoids by reviewing the current scientific literature and thereby provide an opinion on the plausibility of exploring them as potential therapeutical intervention to deal with ongoing CoV-2 pandemic.

scholarly journals Novel corona Virus (2019-nCoV) - An Ancient Ayurveda Epidemiology Literature Review.

2020 ◽  
Vol 8 (02) ◽  
Author(s):  
GANGAPRASAD ANANTRAO WAGHMARE
Keyword(s):  
Mortality Rate ◽  
Severe Acute Respiratory Syndrome ◽  
World Health Organization ◽  
Communicable Disease ◽  
World Health ◽  
Rate Estimate ◽  
Corona Virus ◽  
The World ◽  
Health Organization ◽  
Epidemic Diseases

 Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death   Initially, the World Health Organization (WHO) had mentioned 2% as a mortality rate estimate in a press conference on Wednesday, January 29 and again on February 10. However, on January 29 2020 WHO specified that this was a very early and provisional estimate that might have changed. 3.4% Mortality Rate estimate by the World Health Organization (WHO) as of March 3 2020.                           The concept of epidemic was very much well defined in Ayurveda, Acharya Charaka the great physician of all ages had mentioned the epidemic diseases under the heading of “Janapadodhwans”.The aim of this review study is to understand the ancient Ayurveda epidemic literature , to prevent people from getting affected by epidemic diseases and to enlighten on epidemic diseases prevention & Management through Ayurveda. Keywords: Novel corona Virus (2019-nCoV),severe acute respiratory syndrome,Janapadodhwans,Ayurveda,epidemic Diseases,communicable disease,Panchakarma, Rasayan .  

scholarly journals Impact of COVID-19 on several industries in context with the telehealth and telemedicine industry

2021 ◽  
Vol 2 (4) ◽  
pp. 01-02
Author(s):  
Ashish Gujrathi
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
World Health Organization ◽  
Hubei Province ◽  
World Health ◽  
Growth Opportunities ◽  
Wuhan City ◽  
First Case ◽  
The World ◽  
New Challenges ◽  
Health Organization

Coronavirus (COVID-19) was recognized in late December in Hubei province of Wuhan city in China. This highly contagious disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from humans to humans. After the first case in Wuhan, the disease rapidly spread to other parts of the globe. On March 11, 2020, the World Health Organization (WHO) made an assessment that COVID-19 can be characterized as a pandemic. Thus, social-distancing became an important measure to stop the spread of this disease. Various countries across the world adopted nationwide lockdowns. This led to a completely new scenario for the world, where every business in each industry faced new challenges and witnessed new opportunities. Similarly, the telehealth and telemedicine industry has also witnessed newer growth opportunities.

scholarly journals Loss of Smell and Taste: Potential of Using Them as Markers for Early Detection of Covid-19

2020 ◽  
Vol 3 (2) ◽  
Keyword(s):  
Early Detection ◽  
Severe Acute Respiratory Syndrome ◽  
Virus Disease ◽  
Age Groups ◽  
Viral Disease ◽  
Human Race ◽  
Health Crisis ◽  
Corona Virus ◽  
The World

The world is currently witnessing a severe health crisis of its time. Everyone is juggling and struggling to fight a viral disease named Covid-19 (Corona virus disease 2019) caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). The genome of newly identified virus is less than 30,000 letters long where pathogenesis involve from being asymptomatic to deadly in all age groups. Almost everybody is at a grave risk in such an unpredictable scenario where range of symptoms are so variable from people to people making this pandemic a threat to human race.

scholarly journals Literature Review of Epidemiological Phenomena: Corona Virus Disease Pandemic 2019

2020 ◽  
Vol 2 (3) ◽  
Author(s):  
Yarmaliza Yarmaliza ◽  
Teungku Nih Farisni ◽  
Fitriani Fitriani ◽  
Zakiyuddin Zakiyuddin ◽  
Fitrah Reynaldi ◽  
...  
Keyword(s):  
Virus Infection ◽  
Severe Acute Respiratory Syndrome ◽  
Literature Review ◽  
Virus Disease ◽  
Wuhan City ◽  
Corona Virus ◽  
The World ◽  
History Of ◽  
New Type ◽  
The City

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or Corona virus is a new type of coronavirus that is transmitted to humans. Corona virus infection called COVID-19 (Corona Virus Disease 2019) was first discovered in the city of Wuhan, China at the end of December 2019. Until March 2, 2020, more than 80 thousand confirmed cases have been reported in China. Of these cases, 49 thousand were identified in Wuhan City. Epidemiologically, the spread or distribution of this disease has a wide social and economic impact on the world. Many literature studies about the COVID-19 outbreak, such as causes, natural history of the disease, even to the preventive and medical treatment. Since the end of 2019 until April 2020, there have been many published literature or literature studies at both national and international levels, so this paper aims to examine literature studies related to COVID-19.

Sign in / Sign up

Export Citation Format

Share Document